Advertisement
Screener

Connect Biopharma Holdings Limited (CNTB) Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period

2.3 / 5 stars · 12/26 Roast Me

Connect Biopharma Holdings Limited Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period

Connect Biopharma Holdings Limited (CNTB) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period of 1.98 million shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.

Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod · last filed 2026-03-31

  • Connect Biopharma Holdings Limited share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2025 was 1.98M shares, a 507.23% increase from fiscal 2024.
  • Connect Biopharma Holdings Limited share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2024 was 325.68K shares.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month
2025-12-311.98M shares
10-K · filed 2026-03-31
2024-12-31325.68K shares
10-K · filed 2025-03-31

Similar stocks

Stock NameCountryMarket CapPE Ratio
Yarrow Bioscience, Inc. (YARW)United States$0.070B
PLIANT THERAPEUTICS, INC. (PLRX)United States$0.071B-0.76
TENAX THERAPEUTICS, INC. (TENX)United States$0.071B-7.17
PMV Pharmaceuticals, Inc. (PMVP)United States$0.071B-0.95
Lunai Bioworks Inc. (LNAI)United States$0.072B-0.11
XBiotech Inc. (XBIT)United States$0.066B-1.56
Spero Therapeutics, Inc. (SPRO)United States$0.073B17.41
Cingulate Inc. (CING)United States$0.073B-2.64
HYPERION DEFI, INC. (HYPD)United States$0.065B
Aldeyra Therapeutics, Inc. (ALDX)United States$0.074B-5.57